Anti-Human KIR3DL1/CD158E Rabbit Recombinant Antibody

KIR3DL1/CD158E Uni-rAbTM Recombinant Antibody for FC
Cat No. 98389-1-RR

产品说明书

CloneNo. 243022H8

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

FC

KIR3DL1, CD158 antigen-like family member E, CD158E, CD158E1, HLA-BW4-specific inhibitory NK cell receptor

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格价格库存


经过测试的应用

Positive FC detected inhuman PBMCs

推荐稀释比

应用推荐稀释比
Flow Cytometry (FC)FC : 0.25 ug per 10^6 cells in 100 μl suspension
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

98389-1-RR targets KIR3DL1/CD158E in FC applications and shows reactivity with human samples.

经测试应用 FC Application Description
经测试反应性 human
免疫原 Recombinant protein 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
别名 KIR3DL1, CD158 antigen-like family member E, CD158E, CD158E1, HLA-BW4-specific inhibitory NK cell receptor
计算分子量49 kDa
GenBank蛋白编号NM_013289.4
基因名称 KIR3DL1
Gene ID (NCBI) 3811
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purification
UNIPROT IDP43629-1
储存缓冲液 PBS with 0.09% sodium azide, pH 7.3.
储存条件Store at 2 - 8°C. Stable for one year after shipment.

背景介绍

Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR3DL1 is a receptor on natural killer (NK) cells for HLA Bw4 allele. It inhibits the activity of NK cells thus preventing cell lysis. KIR3DL1 and KIR3DS1 are highly homologous.

实验方案

Product Specific Protocols
FC protocol for KIR3DL1/CD158E antibody 98389-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...